Kremlacek J - Search Results

1

Evaluation of potential aging biomarkers in healthy individuals: telomerase, AGEs, GDF11/15, sirtuin 1, NAD+, NLRP3, DNA/RNA damage, and klotho.

Borsky P, Holmannova D, Andrys C, Kremlacek J, Fiala Z, Parova H, Rehacek V, Svadlakova T, Byma S, Kucera O, Borska L. Borsky P, et al. Among authors: kremlacek j. Biogerontology. 2023 Dec;24(6):937-955. doi: 10.1007/s10522-023-10054-x. Epub 2023 Jul 31. Biogerontology. 2023. PMID: 37523061 Free PMC article.

2

Methods of improving the quality of life in patients with stable maculopathy-pilot results of a new study.

Nekolová J, Kremláček J, Kuba M, Středová M, Morávková D, Drtílková K, Jirásková N. Nekolová J, et al. Among authors: kremlacek j. Cesk Slov Oftalmol. 2019 Summer;75(3):130-135. doi: 10.31348/2019/3/3. Cesk Slov Oftalmol. 2019. PMID: 31779461 Free article. Clinical Trial. English.

3

Electrical brain responses evoked by human faces in acute psychosis.

Valkonen-Korhonen M, Tarkka IM, Pääkkönen A, Kremlacek J, Lehtonen J, Partanen J, Karhu J. Valkonen-Korhonen M, et al. Among authors: kremlacek j. Brain Res Cogn Brain Res. 2005 May;23(2-3):277-86. doi: 10.1016/j.cogbrainres.2004.10.019. Brain Res Cogn Brain Res. 2005. PMID: 15820635

4

The use of optical coherence tomography in chiasmal compression.

Póczoš P, Kremláček J, Česák T, Macháčková M, Jirásková N. Póczoš P, et al. Among authors: kremlacek j. Cesk Slov Oftalmol. 2019 Summer;75(3):120-127. doi: 10.31348/2019/3/2. Cesk Slov Oftalmol. 2019. PMID: 31779460 Free article. English.

5

[Oscillatory potentials in human electroretinography during adaptation to light and dark].

Peregrin J, Svĕrák J, Kremlácek J. Peregrin J, et al. Among authors: kremlacek j. Cesk Slov Oftalmol. 1998 Jan;54(1):3-9. Cesk Slov Oftalmol. 1998. PMID: 9501637 Czech.

6

Possible genotoxic risk of combined exposure to pharmaceutical coal tar and UV-B radiation.

Borská L, Fiala Z, Smejkalová J, Hamáková K, Kremlácek J. Borská L, et al. Among authors: kremlacek j. Cent Eur J Public Health. 2004 Mar;12 Suppl:S14-5. Cent Eur J Public Health. 2004. PMID: 15141964

7

[Genotoxic risk of Goeckerman's therapy of psoriasis. Pilot study--children].

Borská L, Fiala Z, Smejkalová J, Hamáková K, Kremlácek J. Borská L, et al. Among authors: kremlacek j. Acta Medica (Hradec Kralove) Suppl. 2004;47(1):19-21. Acta Medica (Hradec Kralove) Suppl. 2004. PMID: 15745054 Czech.

8

Cytogenetic and immunological changes after dermal exposure to polycyclic aromatic hydrocarbons and UV radiation.

Borská L, Fiala Z, Krejsek J, Hamáková K, Andrýs C, Smejkalová J, Vokurková D, Kremlácek J. Borská L, et al. Among authors: kremlacek j. Physiol Res. 2006;55(3):317-323. doi: 10.33549/physiolres.930787. Epub 2005 Aug 5. Physiol Res. 2006. PMID: 16083312 Free article. Clinical Trial.

9

Selected immunological changes in patients with Goeckerman's therapy TNF-alpha, sE-selectin, sP-selectin, sICAM-1 and IL-8.

Borská L, Fiala Z, Krejsek J, Andrýs C, Vokurková D, Hamáková K, Kremlácek J, Ettler K. Borská L, et al. Among authors: kremlacek j. Physiol Res. 2006;55(6):699-706. doi: 10.33549/physiolres.930928. Physiol Res. 2006. PMID: 16497101 Free article. Clinical Trial.

10

Genotoxic effect of Goeckerman regimen of psoriasis.

Fiala Z, Borska L, Pastorkova A, Kremlacek J, Cerna M, Smejkalova J, Hamakova K. Fiala Z, et al. Among authors: kremlacek j. Arch Dermatol Res. 2006 Oct;298(5):243-51. doi: 10.1007/s00403-006-0691-z. Epub 2006 Aug 11. Arch Dermatol Res. 2006. PMID: 16902768 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page